OTCMKTS:UCBJF - UCB Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding UCB SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $86.85 0.00 (0.00 %) (As of 01/27/2020 04:00 PM ET) Add Compare Today's Range$86.85Now: $86.85▼$86.8550-Day Range$79.60MA: $82.42▼$86.8552-Week Range$68.95Now: $86.85▼$88.67VolumeN/AAverage Volume2,568 shsMarket Capitalization$16.89 billionP/E RatioN/ADividend YieldN/ABeta0.51 ProfileAnalyst RatingsAdvanced ChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:UCBJF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.ucb.com/ Phone32-2559-9999Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees6,828 Outstanding Shares194,510,000Market Cap$16.89 billion Next Earnings DateN/A OptionableNot Optionable Receive UCBJF News and Ratings via Email Sign-up to receive the latest news and ratings for UCBJF and its competitors with MarketBeat's FREE daily newsletter. OTC:UCBJF Rates by TradingView UCB (OTCMKTS:UCBJF) Frequently Asked Questions What is UCB's stock symbol? UCB trades on the OTCMKTS under the ticker symbol "UCBJF." What is the consensus analysts' recommendation for UCB? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UCB in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for UCB. Has UCB been receiving favorable news coverage? Headlines about UCBJF stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. UCB earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for UCB. Who are some of UCB's key competitors? Some companies that are related to UCB include Zoetis (ZTS), Takeda Pharmaceutical (TAK), Allergan (AGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Shiseido (SSDOY), Alexion Pharmaceuticals (ALXN), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), BioMarin Pharmaceutical (BMRN), Genmab A/S (GNMSF), Alnylam Pharmaceuticals (ALNY) and GALAPAGOS NV/S (GLPG). What other stocks do shareholders of UCB own? Based on aggregate information from My MarketBeat watchlists, some companies that other UCB investors own include Airbus (AIR), UCB S A/ADR (UCBJY), Daimler (DDAIF), Radius Health (RDUS), GW Pharmaceuticals PLC- (GWPH), ABLYNX NV/ADR (ABLX) and Circassia Pharmaceuticals (CIR). Who are UCB's key executives? UCB's management team includes the folowing people: Jean-Christophe Tellier, Chief Executive Officer & Executive DirectorCharl van Zyl, Chief Operating OfficerDetlef Thielgen, Chief Financial Officer & Executive Vice PresidentIris Löw-Friedrich, Chief Medical Officer & Executive Vice PresidentDhavalkumar Patel, Chief Scientific Officer & EVP How do I buy shares of UCB? Shares of UCBJF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is UCB's stock price today? One share of UCBJF stock can currently be purchased for approximately $86.85. How big of a company is UCB? UCB has a market capitalization of $16.89 billion. UCB employs 6,828 workers across the globe.View Additional Information About UCB. What is UCB's official website? The official website for UCB is http://www.ucb.com/. How can I contact UCB? UCB's mailing address is 60 ALLEE DE LA RECHERCHE, BRUSSELS C9, 1070. The company can be reached via phone at 32-2559-9999 or via email at [email protected] MarketBeat Community Rating for UCB (OTCMKTS UCBJF)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 207 (Vote Outperform)Underperform Votes: 247 (Vote Underperform)Total Votes: 454MarketBeat's community ratings are surveys of what our community members think about UCB and other stocks. Vote "Outperform" if you believe UCBJF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UCBJF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/27/2020 by MarketBeat.com StaffFeatured Article: What is an Initial Coin Offering (ICO)?
